IDIBELL-Bellvitge Biomedical Research Institute
The Bellvitge Biomedical Research Institute (IDIBELL) was created in 2004. It is the foundation that manages the research activities of Bellvitge University Hospital, the Catalan Oncology Institute, the Bellvitge campus of the University of Barcelona, and the public health companies Institut de Diagnòstic per la Imatge (Image Diagnosis Institute) and Banc de Sang i Teixits (Blood and Tissue Bank). The Institute is the core of Biopol, the health research park of Hospitalet de Llobregat, in the South of Barcelona. The president of the IDIBELL’s managing board is the Catalan Minister of Health, Marina Geli. IDIBELL has more than 500 researchers and manages a budget of almost 22 million euros. The Foundation’s main scientific partners are the University of Barcelona, the Catalan Oncology Institute and the Catalan Health Institute (the managing company of the Bellvitge University Hospital). Since March 2009, it is one of the five research centers accredited by the Spanish Ministry of Health.
'Dark genome' is involved in Rett Syndrome
Researchers at the Epigenetics and Cancer Biology Program at IDIBELL led by Manel Esteller, ICREA researcher and professor of genetics at the University of Barcelona, have described alterations in noncoding ...
Genetics
May 02, 2013 |
3 / 5 (2) |
0
New subtype of ataxia identified
Researchers from the Germans Trias i Pujol Health Sciences Research Institute Foundation (IGTP), the Bellvitge Biomedical Research Institute (IDIBELL), and the Sant Joan de Déu de Martorell Hospital, has identified a new ...
Neuroscience
Apr 29, 2013 |
not rated yet |
0
Three mutations at BRCA1 gene responsible for breast and ovarian hereditary cancer
Researchers of the hereditary cancer research group at the Bellvitge Biomedical Research Institute (IDIBELL) and the Catalan Institute of Oncology (ICO) conducted a functional and structural study of seven missense variants ...
Cancer
Apr 18, 2013 |
not rated yet |
0
Pathological gambling is associated with age
Researchers of the Psychiatry and Mental Health research group at the Bellvitge Biomedical Research Institute (IDIBELL), in the Bellvitge University Hospital, have shown that patient age influences the onset of pathological ...
Psychology & Psychiatry
Apr 08, 2013 |
1 / 5 (1) |
0
About 15 percent of patients with Wolfram syndrome do not meet current diagnostic criteria
Researchers at IDIBELL and CIBERER Virginia Nunes and Miguel López de Heredia have collected data from 400 patients with Wolfram syndrome published worldwide in the last fifteen years to better understand the natural history ...
Genetics
Feb 28, 2013 |
not rated yet |
0
Spanish researchers develop new method to diagnose hereditary breast and ovarian cancer
Researchers of the Catalan Institute of Oncology (ICO) at the Bellvitge Biomedical Research Institute (IDIBELL) have developed and validated a new method to diagnose hereditary breast and ovarian cancer syndrome based on ...
Cancer
Jan 16, 2013 |
not rated yet |
0
Researchers describe a key mechanism in muscle regeneration
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have described a new selective target in muscle regeneration. This is the association of alpha-enolase protein and plasmin. The finding could be used to ...
Medical research
Dec 19, 2012 |
5 / 5 (1) |
0
Inhibition of enzyme NOX4 prevents liver fibrosis
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) have led a study published in PLoS One showing that the inhibition of a family member of NADPH oxidase enzyme, NOX4, plays an important role in liver fibros ...
Diseases, Conditions, Syndromes
Nov 05, 2012 |
4 / 5 (1) |
0
Researchers develop technology that predicts metastasis in breast cancer
Researchers at the Bellvitge Biomedical Research Institute (IDIBELL) and The Institute of Photonic Sciences (ICFO) have collaborated on the development of a diagnostic tool that identifies the metastatic ability of breast ...
Cancer
Oct 18, 2012 |
2 / 5 (1) |
0
An epigenetic difference in twins explains different risk of breast cancer
Monozygotic twins have the same genome, that is, the same DNA molecule in both siblings. Despite being genetically identical, both twins may have different diseases at different times. This phenomenon is ...
Cancer
Oct 17, 2012 |
not rated yet |
0
An immunosuppressive drug could delay the onset of neurodegenerative diseases
Rapamycin, a drug used to prevent rejection in transplants, could delay the onset of neurodegenerative diseases such as Alzheimer's and Parkinson's. This is the main conclusion of a study published in the Nature in which ...
Neuroscience
Oct 15, 2012 |
5 / 5 (1) |
0
New animal models can revolutionize the study of cancer
Some animal models developed by researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL) and the Catalan Institute of Oncology (ICO) has served to validate the effectiveness of a new drug ...
Cancer
Oct 09, 2012 |
not rated yet |
0
New patent on virtual guided-bronchoscopy system to help diagnose lung cancer
A team of researchers from the Institute of Industrial and Control Engineering (IOC) of the Universitat Politècnica de Catalunya · BarcelonaTech (UPC) and the Pulmonology Research Group of the Bellvitge Biomedical Research ...
Cancer
Oct 04, 2012 |
not rated yet |
0
Adult stem cells change their epigenome to generate new organs
A study developed by researchers at the IDIBELL, led by Manel Esteller, has identified epigenetic changes that occur in adult stem cells to generate different tissues of the human body.
Medical research
Oct 02, 2012 |
5 / 5 (2) |
1
Epigenetics emerges powerfully as a clinical tool
A study coordinated by Manel Esteller, published in Nature Reviews Genetics, highlights the success of this area of research to predict the behavior and weaknesses of tumors.
Genetics
Sep 12, 2012 |
not rated yet |
0